Active, not recruitingPhase 2NCT05590468
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy
Studying Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ralitza Gavrilova
- Principal Investigator
- Ralitza H. Gavrilova, MDMayo Clinic
- Intervention
- Nicotinamide Riboside(dietary_supplement)
- Enrollment
- 34 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05590468 on ClinicalTrials.gov